Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction: A Randomized Trial
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAMA
Authors: Marco Valgimigli, Gianfranco Percoco, Patrizia Malagutti, Gianluca Campo, Fabrizio Ferrari, Dario Barbieri, Giordano Cicchitelli, Eugène P. McFadden, Fabia Merlini, Lucia Ansani, Gabriele Guardigli, Alessandro Bettini, Giovanni Parrinello, Eric Boersma, Roberto Ferrari, for the STRATEGY Investigators
Institutions: University of Ferrara, Arcispedale Sant'Anna
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: tirofiban, sirolimus-eluting stent, abciximab, bare-metal stents, ST-elevation myocardial infarction, antiplatelet therapy, percutaneous coronary intervention, target vessel revascularization, restenosis, bleeding complications, cost-effectiveness, reinfarction, major adverse cardiac events, left bundle branch block, glycoprotein IIb/IIIa inhibitors
Open Access status: closed
OpenAlex ID: W2121785565
